Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda M VanDenburgh

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Headache|April 21, 2007
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory studySheena K Aurora, Marek Gawel, Jan L Brandes, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraineJoel R Saper, Ninan T Mathew, Elizabeth W Loder, et al.
Survey of Ophthalmology|March 16, 2004
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trialThomas R Walters, Harvey B DuBiner, Susan P Carpenter, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 22, 2011
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsDavid Wirta, Amanda M Vandenburgh, Emily Weng, et al.
Survey of Ophthalmology|March 16, 2004
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertensionJohn S Cohen, Ronald L Gross, Janet K Cheetham, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionEve J Higginbotham, Joel S Schuman, Ivan Goldberg, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|December 28, 2011
Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticityQuan V Doan, Allison Brashear, Patrick J Gillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysisStuart A Yablon, Mitchell F Brin, Amanda M VanDenburgh, et al.
Headache|September 3, 2011
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical programSheena K Aurora, Paul Winner, Marshall C Freeman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Headache|April 21, 2007
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory studySheena K Aurora, Marek Gawel, Jan L Brandes, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraineJoel R Saper, Ninan T Mathew, Elizabeth W Loder, et al.
Survey of Ophthalmology|March 16, 2004
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trialThomas R Walters, Harvey B DuBiner, Susan P Carpenter, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 22, 2011
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsDavid Wirta, Amanda M Vandenburgh, Emily Weng, et al.
Survey of Ophthalmology|March 16, 2004
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertensionJohn S Cohen, Ronald L Gross, Janet K Cheetham, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionEve J Higginbotham, Joel S Schuman, Ivan Goldberg, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|December 28, 2011
Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticityQuan V Doan, Allison Brashear, Patrick J Gillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysisStuart A Yablon, Mitchell F Brin, Amanda M VanDenburgh, et al.
Headache|September 3, 2011
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical programSheena K Aurora, Paul Winner, Marshall C Freeman, et al.
Pageof 1